C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) C07K 7/23 (2006.01) C07K 14/21 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2323786
The present invention relates to methods for cancer diagnosis using a chimeric toxin. In particular, the invention relates to the use of a chimeric toxin composed of gonadotropin releasing hormone (GnRH) and Pseudomonas exotoxin A (PE) to detect a tumor-associated epitope expressed by human adenocarcinomas. Mutated GnRH-PE molecules that bind but do not kill tumor cells are exemplified.
L'invention concerne des procédés servant à diagnostiquer le cancer au moyen d'une toxine chimère. Elle concerne, en particulier, l'utilisation d'une toxine chimère composée d'une hormone de libération de gonadotrophine (GnRH) et d'une exotoxine A de Pseudomonas (PE) afin de détecter un déterminant antigénique associé à une tumeur et exprimé par des adénocarcinomes humains. Elle cite pour exemple des molécules de GnRH-PE ayant subi une mutation et qui se fixent aux cellules cancéreuses sans les détruire.
Ben-Yehudah Ahmi
Lorberboum-Galski Haya
Marianovsky Irina
Nechushtan Amotz
Yarkoni Shai
Osler Hoskin & Harcourt Llp
Yissum Research Development Company Of The Hebrew University Of
LandOfFree
Methods of cancer diagnosis using a chimeric toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of cancer diagnosis using a chimeric toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of cancer diagnosis using a chimeric toxin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1942271